Levi & Korsinsky is investigating the Board of Directors of Teavana Holdings, Inc. (“Teavana” or the “Company”) (NYSE: TEA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Starbucks Corporation (NasdaqGS: SBUX). Click here to learn more about the investigation http://zlk.9nl.com/teavana-holdings-tea, or call: 877-363-5972. There is no cost or obligation to you. Under the terms of the transaction, Teavana shareholders will receive $15.50 per share of Teavana stock they own. The transaction has a total approximate value of $620 million. The investigation concerns whether the Teavana Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether Starbucks Corporation is underpaying for Teavana shares, thus unlawfully harming Teavana stockholders. In particular, shares of Teavana stock traded higher than the consideration as recently as May 29, 2012. Furthermore, at least one analyst set a price target for Teavana stock at $24.00 per share. If you own common stock in Teavana and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/teavana-holdings-tea. Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.